Merrion Pharmaceuticals Plc (ESM: MERR), a publicly listed product development company announces that Davy has been appointed as the Company's broker and ESM Adviser with immediate effect.
|Merrion Pharmaceuticals Plc.|
|Jonathan O'Connell, Chief Financial Officer||+353 (0)1 642 3300|
|Davy Corporate Finance|
|Ivan Murphy, Director||+353 1 679 6363|
For further information: www.merrionpharma.com
<< Back to Regulatory News